BIOMAT Database Logo BIOMAT Database Logo

[Late results of treatment of chronic pulmonary tuberculosis with rifampicin]. 1973

E Lachowicz, and E Polaczek, and W Araszkiewicz, and H Kozakow, and A Pszonicka, and H Styszewska, and M Janowiec, and R Grabowska

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D012293 Rifampin A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160) Rifampicin,Benemycin,Rifadin,Rimactan,Rimactane,Tubocin

Related Publications

E Lachowicz, and E Polaczek, and W Araszkiewicz, and H Kozakow, and A Pszonicka, and H Styszewska, and M Janowiec, and R Grabowska
[Early results of treatment of patients with chronic pulmonary tuberculosis with rifampicin].
May 1974, Gruzlica i choroby pluc; tuberculosis et pneumonologia,
E Lachowicz, and E Polaczek, and W Araszkiewicz, and H Kozakow, and A Pszonicka, and H Styszewska, and M Janowiec, and R Grabowska
[Late results of 12-month-long hospital treatment of chronic pulmonary tuberculosis with rifampicin combined with other antitubercular agents].
February 1977, Pneumonologia polska,
E Lachowicz, and E Polaczek, and W Araszkiewicz, and H Kozakow, and A Pszonicka, and H Styszewska, and M Janowiec, and R Grabowska
[Delayed results of treatment of pulmonary tuberculosis with rifampicin].
May 1974, Gruzlica i choroby pluc; tuberculosis et pneumonologia,
E Lachowicz, and E Polaczek, and W Araszkiewicz, and H Kozakow, and A Pszonicka, and H Styszewska, and M Janowiec, and R Grabowska
[Preliminary results of treatment of pulmonary tuberculosis with rifampicin].
January 1969, Giornale italiano delle malattie del torace,
E Lachowicz, and E Polaczek, and W Araszkiewicz, and H Kozakow, and A Pszonicka, and H Styszewska, and M Janowiec, and R Grabowska
Late results of treatment of chronic drug-resistant pulmonary tuberculosis.
March 1966, British medical journal,
E Lachowicz, and E Polaczek, and W Araszkiewicz, and H Kozakow, and A Pszonicka, and H Styszewska, and M Janowiec, and R Grabowska
[Late results of treatment of chronic, cavernous pulmonary tuberculosis with reserve drugs].
January 1968, Gruzlica i choroby pluc; tuberculosis et pneumonologia,
E Lachowicz, and E Polaczek, and W Araszkiewicz, and H Kozakow, and A Pszonicka, and H Styszewska, and M Janowiec, and R Grabowska
[Rifampicin in the treatment of chronic pulmonary tuberculosis].
June 1976, Gaceta medica de Mexico,
E Lachowicz, and E Polaczek, and W Araszkiewicz, and H Kozakow, and A Pszonicka, and H Styszewska, and M Janowiec, and R Grabowska
[Treatment of chronic destructive pulmonary tuberculosis with rifampicin and ethambutol].
January 1971, Problemy tuberkuleza,
E Lachowicz, and E Polaczek, and W Araszkiewicz, and H Kozakow, and A Pszonicka, and H Styszewska, and M Janowiec, and R Grabowska
[Treatment of pulmonary tuberculosis with rifampicin].
March 1969, Revue de tuberculose et de pneumologie,
E Lachowicz, and E Polaczek, and W Araszkiewicz, and H Kozakow, and A Pszonicka, and H Styszewska, and M Janowiec, and R Grabowska
[Treatment of pulmonary tuberculosis with rifampicin].
January 1969, Giornale italiano delle malattie del torace,
Copied contents to your clipboard!